Managing Complex HIV Patients 2019

Welcome

The Symposium on Managing Today's Complex HIV Patients took place from 9:00-11:00 AM on 2 October 2019 in Washington, D.C. at IDWeek.

Needs Assessment

Despite improved antiretroviral regimens, virological failure and emergence of drug resistance is still a problem worldwide. This includes both patients recently infected and those veterans of older regimens. Overall, viral suppression among PLWHIV in the USA is 55% and adherence is often sub-optimal. Ultimately, this leads to an increasing number of HIV patients with limited treatment options. Patients with limited treatment options require greater knowledge and understanding to manage in terms of adherence, resistance, aging, comorbidities, and polypharmacy. Thus, they can be considered complex HIV patients. Many HIV-treating clinicians who have entered the field in the last decade have little knowledge of resistance and drug-drug interactions due to the ease at which first-line patients can often be prescribed. HIV physicians need to be educated in identifying and managing the complex HIV patient. HIV physicians need to be educated on new antiretroviral drugs for optimizing treatment of these complex HIV patients.

General Information

Practical Information